Teknova is reiterating its fiscal 2024 outlook for revenue and free cash outflow. The company continues to anticipate total revenue of $35M to $38M for the fiscal year ending December 31 which now assumes roughly 5% growth in Lab Essentials and the remaining dollar revenue from Clinical Solutions. The Company also continues to anticipate free cash outflow of less than $18M for 2024.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TKNO: